Showing results (761-770 of 771) with videos related to
Sort By:
Pageof 78
Emerging Infectious Diseases|May 19, 2006
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza seasonJeffrey C Hageman, Timothy M Uyeki, John S Francis, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Medical Writing Competency Model - Section 2: Knowledge, Skills, Abilities, and BehaviorsDavid B Clemow, Bertil Wagner, Christopher Marshallsay, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Medical Writing Competency Model - Section 1: Functions, Tasks, and ActivitiesDavid B Clemow, Bertil Wagner, Christopher Marshallsay, et al.Cell|September 4, 2021
The origins of SARS-CoV-2: A critical reviewEdward C Holmes, Stephen A Goldstein, Angela L Rasmussen, et al.Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotypeJennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, et al.Nature Communications|February 28, 2018
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 diseaseZhongfang Wang, Lingyan Zhu, Thi H O Nguyen, et al.Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.Science Immunology|April 8, 2017
Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolismA A R Thompson, R S Dickinson, F Murphy, et al.Nature Communications|May 12, 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patientsThi H O Nguyen, Marios Koutsakos, Carolien E van de Sandt, et al.Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.Pageof 78